Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Mechanism underlying Oxigene's tumor vascular targeting agent revealed

June 15, 1999

Protein kinase inhibitors especially useful for cancer in development at BMS

June 14, 1999

Medarex identifies valid Bispecific antibody approach to lymphoma Rx

June 14, 1999

First results of phase I/II trial evaluating arsenic trioxide in CML presented in Barcelona

June 14, 1999

Major licensing agreement announced for former IDEC-Y2B8

June 11, 1999

Bcr-Abl kinase inhibitor CGP-57148B featured at hematology meeting

June 11, 1999

Spongistatin-like cytotoxic agents developed at U. of Pennsylvania

June 11, 1999

Experimental peptide vaccine is safe and effective in patients with CML

June 11, 1999

Japanese patents cover Daiichi's new diphenyl antitumor agents

June 11, 1999

Planned enrollment complete for IntraDose trial, additional patients included

June 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...